ELAN (Elanco Animal Health) Short Interest


ELAN Elanco Animal Health Inc ELAN
66 GF Score
Price $23.96
GF Value $15.57
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Elanco Animal Health Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ELAN vs RGC, NBIX, ALKS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Elanco Animal Health's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elanco Animal Health Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanco Animal Health's Short Interest distribution charts can be found below:

* The bar in red indicates where Elanco Animal Health's Short Interest falls into.


ELAN
66GF Score
Elanco Animal Health Inc ELAN
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Elanco Animal Health (ELAN) Overvalued in 2026?

Based on GuruFocus' analysis, Elanco Animal Health stock appears to be overvalued. The current stock price of $23.96 is trading 53.9% above its estimated GF Value™ of $15.57. GuruFocus considers Elanco Animal Health to be Significantly Overvalued.

Key valuation signals for ELAN:

  • Short Interest:
  • GF Value™: $15.57 vs. price of $23.96 (53.9% above fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the ELAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elanco Animal Health Business Description

Other Exchanges 5EA:Germany
Address 450 ELANCO CIRCLE, INDIANAPOLIS, IN, USA, 46221
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
66GF Score

Get the complete analysis for ELAN

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.96
Price
$15.57
GF Value